Sharon Bio Medicine

Incorporated in 1989 Sharon Bio-Medicine Limited was taken over by the current management in 1995. Sharon is a fast growing Indian Pharmaceutical, Company listed at Bombay Stock Exchange. It is mainly involved in manufacturing of Intermediates, Active Pharmaceutical Ingredients and Finished Dosage Forms with an annual turnover of over $130 million, a work force of over 500 personnel & market presence in over 40 countries worldwide. Sharon is predominantly been known for its strengths in development & manufacturing of Pharmaceutical products right from intermediates to Actives and through to finished Pharmaceuticals.. Sharon is now focusing strongly on developing the Regulated Markets Such as Europe and USA. Sharon’s Oral Solid dosage plant is approved by UK MHRA, Health Canada, Invima (Colombia) and Desktop TGA approval received by its customer. Sharon’s long term focus is to be an integrated service provider for its customers & adding competitive advantage to its customers products throughout its life cycle. Services offered are • Preclinical Toxicology (Offered by SA-FORD-A Division of Sharon Bio Medicine) • Chemical Process Development & Scale up • Formulation Development • Analytical Method Development • DMF & Dossier preparation. (Sharon also undertakes joint development projects for ANDA & CTD Dossiers) • Commercial Manufacturing of Intermediates, Actives, Finished Dosages. • Stability monitoring for the entire shelf life of the product.